Source: FinanzNachrichten

Salix Pharmaceuticals: Bausch Health Companies Inc.: Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, dia...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
500-1.0K
Robert Spurr's photo - President of Salix Pharmaceuticals

President

Robert Spurr

CEO Approval Rating

82/100

Read more